GlobeNewswire by notified

MCH Group | Ad hoc announcement pursuant to Art. 53 LR | Capital increase with the support of its two main shareholders

Share


MCH Group plans a further capital increase with the support of its two main shareholders


MCH Group is planning a further capital increase in order to secure liquidity for the refinancing of its CHF 100 million bond and the further development of the company. The government of the Canton of Basel-Stadt is asking the cantonal parliament to participate in the planned capital increase with an amount of up to CHF 34 million. Under this condition, Lupa Systems will also invest up to CHF 34 million in the company. The capital increase is to be carried out with subscription rights for all shareholders.

Following the pandemic-related losses of the past two years, a financial package of measures is required in order to secure the refinancing of the CHF 100 million bond due in May 2023 and the necessary investments in the company's growth. The focus is on strengthening the capital base with downstream renewal of debt financing. As a first step, MCH Group is planning a further capital increase with subscription rights for all shareholders.

"We have laid the foundations for a successful future during the extremely difficult pandemic years. We have ambitious growth targets, a convincing strategic framework and a concrete implementation plan", says Andrea Zappia, Chairman of the Board of Directors of MCH Group. "The fact that the government of Basel-Stadt as well as Lupa Systems are willing to invest up to CHF 34 million each in MCH Group as part of the planned capital increase underlines that they have every confidence in the path we are taking."

In 2020, the Canton of Basel-Stadt (subject to the approval of the competent bodies) and Lupa Systems had agreed to support the refinancing of the bond in equal parts if the company were unable to refinance it itself. This so-called "backstop" will enable the company to grow after the pandemic.

The government of the Canton of Basel-Stadt is therefore proposing to the parliament that the canton participate in the planned capital increase through the acquisition of new capital shares in the amount of up to CHF 34 million. This means that the public entities participating in the MCH Group will continue to hold at least 33.34 % of the shares and voting rights.

In the 2020 capital increases, the Canton of Basel-Stadt had converted CHF 24.2 million of an existing interest-free loan of CHF 30 million into equity. When it joined MCH Group, Lupa Systems had envisaged a maximum investment amount of CHF 75 million and had invested CHF 48 million as part of the capital increases in 2020. In the case of the capital increase now planned, Lupa Systems is also willing to invest up to CHF 34 million, in the same way as the Canton of Basel-Stadt, and thus to go beyond the originally planned maximum investment amount, if necessary.

Furthermore, the government is proposing to the parliament that repayment of the remaining loan of CHF 5.8 million that was not converted into equity in 2020 should be waived. This had likewise been envisaged in 2020 already and is now also justified by the fact that MCH Group was not entitled to Corona hardship funds from the Swiss Confederation due to the participation of the public entities.

Once a legally binding parliamentary decision has been taken, MCH Group will submit the capital increase to its shareholders at an Extraordinary General Meeting. The concrete modalities – in particular the issue price and the requirements under takeover law – will be drawn up in the coming months.




Contacts

Media Relations:

Emanuel Kuhn
Head of Corporate Communications
+41 58 206 22 43
emanuel.kuhn@mch-group.com

Investor Relations:

Christian Jecker
+ 41 58 206 22 52
christian.jecker@mch-group.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Tenaris Announces 2024 First Quarter Results25.4.2024 22:30:25 CEST | Press release

The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented in U.S. dollars and prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standard Board and adopted by the European Union, or IFRS. Additionally, this press release includes non-IFRS alternative performance measures i.e., EBITDA, Net cash / debt, Free Cash Flow and Operating working capital days. See exhibit I for more details on these alternative performance measures. LUXEMBOURG, April 25, 2024 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris”) today announced its results for the quarter ended March 31, 2024 in comparison with its results for the quarter ended March 31, 2023. Summary of 2024 First Quarter Results (Comparison with fourth and first quarter of 2023) 1Q 20244Q 20231Q 2023Net sales ($ million)3,4423,4151%4,141(17%)Operating

Combined General Meeting of May 16, 202425.4.2024 22:30:00 CEST | Press release

Châtillon, France, April 25, 2024 Combined General Meeting of May 16, 2024 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need (the “Company”), will hold its Combined General Meeting (the “General Meeting”) on May 16, 2024, at 10:00 a.m. CET at the Company’s new headquarters located at IRO Building, 107 Avenue de la République, 92320 Châtillon, France. The preliminary notice (avis de réunion) containing the detailed agenda, draft resolutions as well as instructions to participate and vote for this General Meeting was published in the French “Bulletin des Annonces Légales Obligatoires (BALO)” dated April 8, 2024 (No. 2400716). The meeting notice (avis de convocation) will be published in the BALO and in t

Millicom (Tigo) Board of Directors Appoints Marcelo Benitez as CEO25.4.2024 22:30:00 CEST | Press release

Millicom (Tigo) Board of Directors Appoints Marcelo Benitez as CEO Luxembourg, April 25, 2024 – Millicom announced today that its Board of Directors has appointed Marcelo Benitez as CEO of Millicom, effective June 1, 2024. Benitez has had a distinguished career with Millicom, having joined the company in Paraguay nearly 30 years ago and risen through the Company’s ranks to his most recent role as CEO of TIGO Panama. Benitez's selection completes the final phase of a succession planning and selection process, which included a thorough evaluation of internal and external candidates to ensure that the company's next CEO possesses the vision, experience, talent and leadership qualities necessary to deliver on Millicom's strategic plans. "After an extensive evaluation, it is clear to our Board that Marcelo is the right person to lead Millicom into the future”, indicated Mauricio Ramos, Chair of the Board of Directors of the Company. Under Marcelo’s leadership, TIGO Panama completed the succ

Mohawk Industries Reports Q1 Results25.4.2024 22:10:00 CEST | Press release

CALHOUN, Ga., April 25, 2024 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK) today announced first quarter 2024 net earnings of $105 million and earnings per share (“EPS”) of $1.64; adjusted net earnings were $119 million, and adjusted EPS was $1.86. Net sales for the first quarter of 2024 were $2.7 billion, a decrease of 4.5% as reported and 5.5% on a legacy and constant basis versus the prior year. During the first quarter of 2023, the Company reported net sales of $2.8 billion, net earnings of $80 million and EPS of $1.26; adjusted net earnings were $112 million, and adjusted EPS was $1.75. Commenting on the Company’s first quarter results, Chairman and CEO Jeff Lorberbaum stated, “Though economic headwinds are impacting industry sales, margins and mix, our first quarter results reflected the positive effect of actions we are taking to enhance our performance. Our earnings per share rose year over year as a result of restructuring, productivity initiatives and benefits from

Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®25.4.2024 22:05:00 CEST | Press release

CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE™ to the reference product ROACTEMRA® CAMBRIDGE, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for TOFIDENCE™ (tocilizumab), a biosimilar monoclonal antibody referencing ROACTEMRA®1. The intravenous formulation of TOFIDENCE has been recommended for approval for the treatment of moderate to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis and COVID-19. The CHMP’s positive opinion will now be referred to the European Commission (EC), which will decide whether to grant marketing authorization for TOFIDENCE. If a marketing authorization is granted by the EC, TOFIDENCE will be an addition to the existing biosimilars portfolio of three widely p

HiddenA line styled icon from Orion Icon Library.Eye